SCHEMBL9541529

SCHEMBL9541529

O=C(c1ccccc1)c1cc([N+](=O)[O-])ccc1NC(=O)n1ccnc1

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.59
MAPT P10636 4/20 0.47
LMNA P02545 3/20 0.47
POLB P06746 1/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PIN1 Q13526 1/20 0.46
AKR1C4 P17516 1/20 0.46
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
AKR1C1 Q04828 1/20 0.46
ALDH1A1 P00352 2/20 0.44
GAA P10253 1/20 0.44
CTSV O60911 1/20 0.43
CTSL P07711 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2469763 0.83 CYP19A1 (0.43) CYP19A1MAPTLMNAALDH1A1GAA
SCHEMBL2468850 0.82 MAPT (0.56) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL7752904 0.78 AKR1C4 (0.67) MAPTPOLBPIN1AKR1C4AKR1C3
SCHEMBL8578400 0.78 MAPT (0.73) CYP19A1MAPTLMNAPOLBHTT
SCHEMBL6811878 0.77 CYP19A1 (0.59) CYP19A1MAPTLMNAPOLBHTT
SCHEMBL10912944 0.77 CYP19A1 (0.64) CYP19A1MAPTLMNAPOLBHTT
SCHEMBL7752953 0.76 PIN1 (0.56) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL27346954 0.75 MAPT (0.56) CYP19A1MAPTLMNAPOLBHTT
SCHEMBL8568341 0.74 AKR1C4 (0.52) MAPTLMNAPOLBHTTSMN1; SMN2
SCHEMBL6545840 0.74 AKR1C4 (0.52) MAPTLMNAPOLBHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed